Recent Company News

• 02:00 PM ET Feb 09, 2026
  

  StreetAccount Summary - Private Company Weekly Recap - Week of 2-Feb

• 12:40 PM ET Feb 06, 2026
  

  AgomAb Therapeutics NV IPO opens at $14.70 on the Nasdaq

• 10:49 AM ET Feb 06, 2026
  

  AgomAb Therapeutics NV now indicated to open at $15.25/ADS, priced at $16

• 10:13 AM ET Feb 06, 2026
  

  AgomAb Therapeutics NV indicated to open at $18.50/ADS

• 09:19 AM ET Feb 06, 2026
  

  StreetAccount Summary - US Syndicate recap for 06-Feb

• 08:52 AM ET Feb 06, 2026
  

  StreetAccount Summary - US Initial Syndicate recap for 06-Feb

• 08:27 AM ET Feb 06, 2026
  

  AgomAb Therapeutics NV IPO scheduled to begin trading at 10:20ET on the Nasdaq

• 02:40 AM ET Feb 06, 2026
  

  StreetAccount Summary - EU equity offerings recap, week of 2-Feb